富国生物医药科技混合C(011308)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
5,997,329.23 |
8,267,607.36 |
6,478,082.09 |
9,043,466.19 |
| 存出保证金 |
170,376.75 |
135,025.72 |
162,837.88 |
149,728.64 |
| 交易性金融资产 |
408,720,543.57 |
484,757,059.87 |
455,766,205.32 |
658,098,300.34 |
| 其中:股票投资 |
408,720,543.57 |
480,569,968.40 |
447,200,231.35 |
652,484,276.94 |
| 债券投资 |
- |
4,187,091.47 |
8,565,973.97 |
5,614,023.40 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
137,965.00 |
- |
- |
2,445,143.33 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
26,544.00 |
119,443.79 |
- |
389.56 |
| 应收申购款 |
829,846.88 |
195,869.67 |
219,521.28 |
237,012.86 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
455,781,888.80 |
554,481,119.72 |
494,162,151.82 |
720,050,743.87 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
56.02 |
5,420,111.24 |
2,894,888.57 |
2,432,143.81 |
| 应付赎回款 |
5,090,323.94 |
1,744,518.19 |
2,132,509.97 |
465,522.78 |
| 应付管理人报酬 |
489,100.56 |
551,451.27 |
529,167.17 |
738,430.65 |
| 应付托管费 |
81,516.77 |
91,908.50 |
88,194.57 |
123,071.78 |
| 应付销售服务费 |
27,453.45 |
13,828.22 |
18,492.48 |
28,764.95 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
14.86 |
4.90 |
13.66 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
355,400.77 |
704,341.49 |
547,035.39 |
934,219.24 |
| 负债合计 |
6,043,851.51 |
8,526,173.77 |
6,210,293.05 |
4,722,166.87 |
| 所有者权益 |
| 实收基金 |
243,513,571.68 |
299,680,223.35 |
345,579,332.41 |
469,338,389.23 |
| 未分配利润 |
206,224,465.61 |
246,274,722.60 |
142,372,526.36 |
245,990,187.77 |
| 所有者权益合计 |
449,738,037.29 |
545,954,945.95 |
487,951,858.77 |
715,328,577.00 |
| 负债及所有者权益总计 |
455,781,888.80 |
554,481,119.72 |
494,162,151.82 |
720,050,743.87 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年